Answers are grounded in this paper and cite their sources.
Cervical cancer remains a major public health challenge in Cameroon, where important gaps persist in HPV vaccination, screening, and treatment. This review synthesizes published evidence and programme experience to assess progress in implementing the World Health Organization (WHO) cervical cancer elimination strategy and to identify priorities for national scale-up. We reviewed peer-reviewed literature and publicly available programme and technical documents published between 2015 and 2026, focusing on HPV vaccination, HPV self-sampling, screen–triage–treat approaches, risk-stratified triage, telecytology, artificial intelligence (AI)-assisted diagnostics, integration with HIV services, and health-system strengthening. HPV vaccination coverage has improved following adoption of a gender-neutral, single-dose strategy but remains below the WHO target. Cervical cancer screening coverage remains very low, whereas HPV-based screen–triage–treat approaches, self-sampling, thermal ablation, and integration with HIV care platforms show potential to simplify care and reduce loss to follow-up. Extended HPV genotyping and telecytology may improve risk-adapted management and access to specialist expertise, while AI-assisted diagnostics remain investigational and require prospective validation. Major constraints include workforce shortages, fragmented referral pathways, limited diagnostic and treatment capacity, supply-chain weaknesses, and inadequate sustainable financing. Cameroon has generated valuable implementation experience, but the next phase should focus on transitioning from fragmented pilot initiatives to a coordinated national programme supported by strong governance, sustainable financing, digital health infrastructure, and implementation research.
No takes yet. Share an insight, caveat, or question.
Vassilakos et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: